CK Life Sciences' Sequencio Therapeutics to Present New Data from Lead Cancer Vaccine Programmes at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting
HONG KONG SAR - Media OutReach Newswire - 4 November 2026 - Sequencio Therapeutics Company Limited ("Sequencio"), a subsidiary of CK Life Sciences Int'l., (Holdings) Inc. ("CK Life Sciences"), today announced that the Society for Immunotherapy of Cancer (SITC) has selected two abstracts from Sequencio for presentation at its 41st Annual Meeting, taking place 4-8 November 2026 in Phoenix, Arizona,...
read full article
